HIGHLIGHTS
- who: Angelika Costard-Jäckle from the Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center Northrhine Westfalia, University Hospital, Ruhr-University Bochum, Georgstr11, Bad Oeynhausen, Germany have published the Article: Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response, in the Journal: (JOURNAL)
- what: The authors report the results of a prospective study on the immunogenicity of a 3rd dose of BNT162b2 in thoracic organ recipients with no or minimal response following a two-dose BNT162b2 vaccination scheme. The authors report the experience with a third BNT162b2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.